← FDA DRUG APPROVALS

FDA ANDA · ANDA075734

HYDROXYUREA

Sponsor: BARR

APPLICATION
ANDA075734
TYPE
ANDA
ORIGINAL APPROVAL
2000-08-29
LATEST ACTION
2002-01-18
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

HYDROXYUREADiscontinued
HYDROXYUREA 1GM · TABLET · ORAL

Approval history

2002-01-18Manufacturing (CMC) · Supplement 1AP
2001-09-27Labeling · Supplement 2AP
2000-08-29OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →